Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults
Study Identifier
GMA-US-NEU-0206
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Statistical Analysis Plan
Available Language(s): English
Protocol
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 4
Sex
Female & Male
Age
18 - 65 Years
Protocol Summary
This study will evaluate the efficacy, safety and tolerability of prophylactic (preventative) treatment with BOTOX® (onabotulinumtoxinA) compared to topiramate in adults with chronic migraine.
Study Locations
Location
Status
Location
St Joseph's Hospital Barrow Neurology Clinics
Phoenix, Arizona, United States, 85013
Status
Not applicable
Location
North County Neurology Associates
Encinitas, California, United States, 92024
Status
Not applicable
Location
California Headache and Balance Center
Fresno, California, United States, 93723
Status
Not applicable
Location
Newport Beach Clinical Research Associates, Inc.
Newport Beach, California, United States, 92663
Status
Not applicable
Location
Denver Neurological Clinic
Denver, Colorado, United States, 80210
Status
Not applicable
Location
Ki Health Partners LLC DBA New England Institute for Neurology and Headache
Stamford, Connecticut, United States, 06905
Status
Not applicable
Showing {first} - {last} of {total} Results